Vimarsana
Biggest News Aggregation in the World

Group Comparative Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group Comparative Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group Comparative Trial Today - Breaking & Trending Today

Probiotic shows promise for reducing frequency of common cold symptoms - Vimarsana News

Probiotic shows promise for reducing frequency of common cold symptoms

Susceptibility to common cold symptoms such as runny nose, sneezing, and sore throat, could be reduced by supplementing with probiotic LAB strain Lactobacillus paragasseri SBT2055 (LG2055), particularly in people with weakened immunity, a new study has concluded.

Probiotic shows promise for reducing frequency of common cold symptoms - Vimarsana News

Probiotic shows promise for reducing frequency of common cold symptoms

Susceptibility to common cold symptoms such as runny nose, sneezing, and sore throat, could be reduced by supplementing with probiotic LAB strain Lactobacillus paragasseri SBT2055 (LG2055), particularly in people with weakened immunity, a new study has concluded.